Skip to main content

Niznik accepted as one of 12 AGING Initiative MCCs Scholars

February 18, 2022

Joshua Niznik, PharmD, PhD was recently accepted into the AGING Initiative MCCs Scholars Program. As one of twelve MCCs Scholars, Dr. Niznik will attend an in-person workshop in Washington D.C. this spring. In addition, he will attend 6 webinars during his scholarship year.

Deprescribing in Older Adults: an Interview with Josh Niznik, PharmD, PhD

February 13, 2020

“More than half of older adults are exposed to polypharmacy and the unfortunate thing is that those people are more susceptible to side effects and they’re more vulnerable to drug-drug interactions. It’s important for physicians, patients, and caregivers to realistically discuss the benefits a medication can and can’t provide, and to have a plan for de-escalating or stopping certain medications.”

Addressing Overmedication in Nursing Home Patients with Severe Dementia

January 13, 2020

A recent study from Assistant Professor Joshua Niznik, PhD, PharmD, Division of Geriatric Medicine, in the Journal of American Geriatrics Society suggests de-prescribing Acetylcholinesterase Inhibitors (AChEls) as a reasonable approach to lowering polypharmacy and risk of serious falls or fractures without increasing risk for all-cause negative events in nursing home residents with severe dementia. Co-authors … Continued